Sign inJoin waitlistJoin the waitlist

BN

Brian Nickoloff

Pathology / Dermatopathology

Credentials: ·

Research

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
The Lancet · 2015 · 696 citations
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
New England Journal of Medicine · 2016 · 681 citations
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model
Nature Medicine · 2005 · 617 citations

JV
John Voorhees
24 papers
BB
Brian Bonish
17 papers · 8 as a resident
LT
Laurence Turka
17 papers
VM
Vera Morhenn
17 papers
CE
Charles Ellis
10 papers
Craig Thompson
10 papers
DF
David Fivenson
9 papers
Jonathan Curry
8 papers · 8 as a resident
June Robinson
8 papers
Kevin Cooper
8 papers
AC
Alfred Chang
6 papers
Gary Wood
6 papers · 5 as a resident